Market research
5OT.SG Singapore Medical Group Limited
SG SGD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 192M
- P/E ratio
- 13.17
- Analyst target
- 0.45
- Dividend yield
- 1.7%
- Beta
- 0.62
Profile
Company facts
- Exchange
- SG
- Currency
- SGD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- SG1Y37945678
- Market cap
- 192M
- P/E ratio
- 13.17
- Analyst target
- 0.45
- Dividend yield
- 1.7%
- Beta
- 0.62
About
About Singapore Medical Group Limited
Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services. The Diagnostic & Aesthetics Business segment provides radiology and diagnostic imaging services; refractive surgery services; dental services, including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery, and gum treatment; and aesthetics medicine services consisting of facial aesthetics, body aesthetics, facial and breast fillers, IPL, lasers, Botox, microdermabrasion minimally invasive Silhouette threadlift, VASER-assisted LipoSelection, and plastic surgery. The Others segment offers business consultancy and telemedicine services. The company also offers breast related medical services; develops software/e-commerce applications for medical related services, as well as operates approximately 30 clinics. The company was incorporated in 2005 and is based in Singapore.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 5OT.SG discussion.
5 years, 4 months ago
Singapore Medical Group Limited is currently in a long term downtrend where the price is trading 5.3% below its 200 day moving average.
From a valuation standpoint, the stock is 74.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Singapore Medical Group Limited's total revenue rose by 237.8% to $87M since the same quarter in the previous year.
Its net income has increased by 137.0% to $9M since the same quarter in the previous year.
Finally, its free cash flow fell by 29.9% to $5M since the same quarter in the previous year.
Based on the above factors, Singapore Medical Group Limited gets an overall score of 3/5.